Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

248
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
248
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

267
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
267
Tumor Immunotherapy01:27

Tumor Immunotherapy

504
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
504

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A wireless subdural-contained brain-computer interface with 65,536 electrodes and 1,024 channels.

Nature electronics·2026
Same author

Hereditary angioedema attack trends among patients maintained on lanadelumab long-term prophylaxis.

The journal of allergy and clinical immunology. Global·2026
Same author

Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema.

The New England journal of medicine·2026
Same author

Investigating the Dynamic Relationship Between Anxiety and Spatial Memory Using Autonomous Ecological Momentary Assessment.

Research square·2026
Same author

Hidden Spirals Reveal the Neurocomputational Mechanisms of Traveling Waves in Human Memory.

bioRxiv : the preprint server for biology·2026
Same author

Evaluating place cell detection methods in Rats and Humans: Implications for cross-species spatial coding.

PLoS computational biology·2026

Related Experiment Video

Updated: Jun 20, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.1K

Oral immunotherapy using weight by volume solutions.

Karna Gendo1, Tony Orden1, Allyson Tevrizian1

  • 1From the Allergy and Asthma Medical Group of the Bay Area, and Walnut Creek, California.

Journal of Food Allergy
|July 18, 2024
PubMed
Summary
This summary is machine-generated.

Adapting subcutaneous immunotherapy (SCIT) methods to oral immunotherapy (OIT) simplifies OIT preparation and may enhance safety through clearer dosing. This approach aims to improve OIT

More Related Videos

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.2K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

16.9K

Related Experiment Videos

Last Updated: Jun 20, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.1K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.2K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

16.9K

Area of Science:

  • Allergy and Immunology
  • Immunotherapy Research
  • Clinical Trial Adaptation

Background:

  • Subcutaneous immunotherapy (SCIT) is a common treatment for allergic diseases.
  • Oral immunotherapy (OIT) offers an alternative route of administration but faces implementation challenges.
  • Standardizing OIT protocols is crucial for wider clinical adoption.

Purpose of the Study:

  • To adapt established subcutaneous immunotherapy (SCIT) methods for oral immunotherapy (OIT).
  • To evaluate the impact of adapted SCIT methods on OIT implementation.
  • To assess potential improvements in safety and ease of use for OIT.

Main Methods:

  • Review and adaptation of existing SCIT protocols for OIT administration.
  • Development of simplified solution preparation guidelines for OIT.
  • Analysis of dosing transparency and safety considerations in the adapted OIT protocol.

Main Results:

  • Adapted SCIT methods streamline OIT solution preparation.
  • The adapted protocol enhances dosing transparency in OIT.
  • Potential for improved safety profile in OIT due to clearer dosing.

Conclusions:

  • Adapting SCIT protocols offers a practical approach to OIT implementation.
  • Simplified preparation and improved dosing transparency can enhance OIT safety.
  • This adaptation strategy may facilitate broader use of OIT in clinical practice.